Matriptase is possibly involved in this as the serine protease is expressed by the tumor cells themselves and CVS-3983, a matriptase inhibitor, has been developed and shown to retard tumor growth in a human prostate cancer xenograft model [33]. This evidence concerns the gene ST14 and prostate cancer.